Cargando…

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?

Detalles Bibliográficos
Autores principales:	Passiglia, Francesco, Novello, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932644/ https://www.ncbi.nlm.nih.gov/pubmed/36816346 http://dx.doi.org/10.1016/j.eclinm.2023.101845

Ejemplares similares

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

Role of adjuvant treatment in stage IB non-small cell lung carcinoma
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

Should the USA Offer Reparations to Africa for the Transatlantic Slave Trade?
por: Howard-Hassmann, Rhoda E.
Publicado: (2022)

Comment on: Should bariatric surgery be offered to prisoners?
por: Friedman, Danielle T., et al.
Publicado: (2020)

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer
por: Zhang, Pei, et al.
Publicado: (2020)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
por: Passiglia, Francesco, et al.
Publicado: (2021)

The case for SABR as the global standard for non-operable early-stage non-small cell lung cancer
por: Mutsaers, Adam, et al.
Publicado: (2022)

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022)

Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer
por: Xu, Yangyang, et al.
Publicado: (2022)

Adjuvant Chemotherapy With Sequential Cytokine-Induced Killer (CIK) Cells in Stage IB Non-Small Cell Lung Cancer
por: Li, Da-Peng, et al.
Publicado: (2015)

Adjuvant atezolizumab in Japanese patients with resected stage IB‐IIIA non‐small cell lung cancer (IMpower010)
por: Kenmotsu, Hirotsugu, et al.
Publicado: (2022)

A Novel Nomogram for Identifying Candidates for Adjuvant Chemotherapy in Patients With Stage IB Non-small Cell Lung Cancer
por: Song, Xue, et al.
Publicado: (2023)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience
por: Capelletto, Enrica, et al.
Publicado: (2020)

Spinning the legs and blood: should intradialytic exercise be routinely offered during maintenance haemodialysis?
por: Graham-Brown, Matthew P M, et al.
Publicado: (2021)

Efficacy of platinum-based adjuvant chemotherapy in T2aN0 stage IB non-small cell lung cancer
por: Park, Seong Yong, et al.
Publicado: (2013)

Overall Survival Analyses following Adjuvant Chemotherapy or Nonadjuvant Chemotherapy in Patients with Stage IB Non-Small-Cell Lung Cancer
por: Tu, Zegui, et al.
Publicado: (2021)

Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Xiaofan, et al.
Publicado: (2021)

Adjuvant chemotherapy or immunotherapy for completely resected stage IB non-small cell lung cancer: still a grey zone?
por: Lee, Kuan-Yu, et al.
Publicado: (2023)

Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies
por: Cani, Massimiliano, et al.
Publicado: (2023)

Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors
por: Choi, Juwhan, et al.
Publicado: (2022)

Who should be offered non-radical surgery for early-stage cervical cancer?
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2015)

Porous organic materials offer vast future opportunities
por: Liu, Tianyu, et al.
Publicado: (2020)

Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer
por: Hao, Bo, et al.
Publicado: (2020)

Metabolite medicine offers a path beyond lists of metabolites
por: Shaham-Niv, Shira, et al.
Publicado: (2021)

Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma
por: Zhai, Wenyu, et al.
Publicado: (2022)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
por: Gandaglia, Giorgio, et al.
Publicado: (2023)

Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non‐predominant lung adenocarcinoma
por: Cao, Shuhui, et al.
Publicado: (2018)

Evaluation of the significance of subcarinal lymph node dissection in stage IB non‑small cell lung cancer
por: Wang, Feng, et al.
Publicado: (2023)

BCG-induced trained immunity: can it offer protection against COVID-19?
por: O’Neill, Luke A. J., et al.
Publicado: (2020)

What does the global south have to offer for global health and well-being?
por: Patwardhan, Bhushan, et al.
Publicado: (2023)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021)

Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
por: Herbst, Roy S., et al.
Publicado: (2023)

Treatment Modality for Stage IB Peripheral Non-Small Cell Lung Cancer With Visceral Pleural Invasion and ≤3 cm in Size
por: Huang, Weijia, et al.
Publicado: (2022)

Adjuvant Chemotherapy for Early Stage Non-Small Cell Lung Cancer
por: Patel, Manali I., et al.
Publicado: (2011)

Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer
por: Wang, Bing-Yen, et al.
Publicado: (2016)

When failure should be the option
por: Petsko, Gregory A
Publicado: (2010)

Blind free-living kiwi offer a unique window into the ecology and evolution of vertebrate vision
por: Moore, Bret A., et al.
Publicado: (2017)

SARS-CoV-2 variants offer a second chance to fix vaccine inequities
por: Hotez, Peter J.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jornf36p9a9iin964vnmhtv4ue